BWT-51218-72101
3 vaccinations
3 coded responses
39 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 220 / VA
- Registered
- 2021-04-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-27
Registered in v-safe
-
2021-04-27
Dose 1 — Pfizer-BioNTech
- 2021-04-27
-
2021-04-28
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: Pain · HeadacheFree text: Minor bruising by injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-04
- 2021-05-11
-
2021-05-20
Dose 2 — Pfizer-BioNTech
- 2021-05-20
- 2021-05-21
- 2021-05-22
- 2021-05-23
- 2021-05-24
- 2021-05-25
- 2021-05-26
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-06-17
- 2021-06-24
- 2021-07-02
- 2021-08-19
- 2021-11-20
-
2021-12-27
Dose 3 — Pfizer-BioNTech
-
2021-12-27
Survey response — day 0, dose 3MedDRA: Abdominal distension, Muscle spasms — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Bloated, crampyMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-03
Health check-in — day 7, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-10
- 2022-01-17
- 2022-01-24
- 2022-01-31
-
2022-02-07
Survey response — day 42, dose 3MedDRA: Hospitalisation, Nephrolithiasis, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: In hospital currently with suspected kidney stones, or possible kidney infection. Been here 2 days so far. Currently 15 weeks pregnant.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-07
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-02-10
- 2022-03-29
- 2022-06-27
- 2022-12-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-27 | Pfizer-BioNTech | |
| 2 | 2021-05-20 | Pfizer-BioNTech | |
| 3 | 2021-12-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Minor bruising by injection site.
Release 10 — day 0, dose 3
Systemic reaction (other): Bloated, crampy
Release 11 — day 42, dose 3
Symptoms: In hospital currently with suspected kidney stones, or possible kidney infection. Been here 2 days so far. Currently 15 weeks pregnant.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hospitalisation | · | · | ✓ |
| SD | Nephrolithiasis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Abdominal distension | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release